Product Information

ROSUVASTATIN CALCIUM 5 MG TAB is a generic product labeled by Cranbury Pharmaceuticals, LLC, priced at $0.0333 per EA under NDC 27808015501. Its NADAC has been published 428 times since Jun 13, 2018.

FDA first approved this application on Oct 31, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROSUVASTATIN CALCIUM 5 MG TAB

Rosuvastatin Calcium
$0.0333per EA

Strength

5 mg/1

NDC

27808015501

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ROSUVASTATIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA207408

FDA Approved

10/31/2016

TE Code

AB

On Market Since

1/8/2018

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has been published 428 times since Jun 13, 2018, and over the history we have for it it has declined 70.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0333 per EA
All-time high$0.1139 (Jun 13, 2018)
All-time low$0.0333 (Aug 19, 2026)
52-week high$0.0389
52-week low$0.0333
Median price$0.0575
Average price$0.0649
Largest weekly change-22.3% (Dec 20, 2023)
Weeks tracked428
Tracking sinceJun 13, 2018

Price History

1W

-2.0%

1M

-2.0%

3M

-4.7%

6M

-2.5%

1Y

-14.5%

3Y

-32.2%

5Y

-59.8%

All

-70.8%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ROSUVASTATIN CALCIUM 5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 5 MG TAB, manufactured by Cranbury Pharmaceuticals, LLC, is $0.0333 per EA (NDC 27808015501), effective Aug 19, 2026.

How has the price of ROSUVASTATIN CALCIUM 5 MG TAB changed over time?

Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has declined 70.8%. It has been tracked across 428 weekly CMS publications since Jun 13, 2018.

What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 5 MG TAB?

Since Jun 13, 2018, the NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has ranged from a low of $0.0333 (Aug 19, 2026) to a high of $0.1139 (Jun 13, 2018), with a median of $0.0575 per EA.

Are there cheaper alternatives to ROSUVASTATIN CALCIUM 5 MG TAB?

11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ROSUVASTATIN CALCIUM 5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures ROSUVASTATIN CALCIUM 5 MG TAB?

ROSUVASTATIN CALCIUM 5 MG TAB (NDC 27808015501) is labeled by Cranbury Pharmaceuticals, LLC, and CMS classifies it as a generic product.